#EIJonAir
Join our upcoming live X video chat on Immediate versus staged complete revascularisation in patients presenting with STEMI and multivessel disease with Paola Scarparo and Waqar Ahmed.
Join us on our social media channels, live on Thursday 25 July at 5:30 PM (CET - Paris time)
Viewpoint
This article discusses growing evidence that moderate aortic stenosis can negatively impact prognosis, leading to ongoing trials evaluating whether transcatheter aortic valve implantation (TAVI) may provide benefit over medical therapy for these patients.
ORIGINAL RESEARCH
EDITORIAL
This article argues that while ultrasound guidance can help reduce vascular access complications with transfemoral access, it is not a panacea, and the cardiology community needs to focus on training interventionalists in ultrasound-guided transfemoral access techniques.
ORIGINAL RESEARCH
In patients with STEMI and multivessel disease, immediate and staged complete revascularization strategies resulted in similar clinical outcomes at 1 year.
STATE-OF-THE-ART
INTERVENTIONAL FLASHLIGHT
The paper describes the Splitter, a novel device that performs leaflet modification by cusp splitting and partial leaflet excision to reduce the risk of coronary occlusion in transcatheter aortic valve-in-valve implantation procedures.
Research Correspondence
The EASTBOURNE Registry suggests that sirolimus-coated balloon angioplasty is safe and effective, with low rates of clinically relevant adverse events at 2-year follow-up, in both de novo coronary artery disease and in-stent restenosis.
Original Research
The main factors associated with target lesion failure after PCI with a DCB for de novo lesions were the presence of hemodialysis, severe coronary artery calcification, and the absence of post-PCI medial dissection on OCT imaging.
Editorial
The article discusses the potential challenges and unanswered questions around using a drug-coated balloon-only strategy for treating de novo coronary lesions, especially regarding the need for adequate lesion preparation and the long-term safety and efficacy compared to drug-eluting stents.
EXPERT REVIEW
This article discusses how cerebrovascular events remain a significant concern after transcatheter aortic valve implantation (TAVI) procedures, despite advancements in technology, and highlights the need for improved patient risk assessment, use of cerebral embolic protection devices, and further research into the relationship between TAVI and neurological outcomes.
VIEWPOINT
IMPACT FACTOR
We are pleased to announce that EuroIntervention’s Impact Factor is now 7.6. This increase of 1.4 compared to last year places the journal at 21st out of 221 journals in the cardiovascular field, marking a year of significant growth and achievement. The Editorial Board extends its thanks to all the readers, authors, reviewers and editors whose collaboration have made this success possible.
